The Impact of COVID-19 on Tobacco Regulation: Challenges and Considerations

Oct.10.2023
The Impact of COVID-19 on Tobacco Regulation: Challenges and Considerations
New scientific data contradicts the belief that the COVID-19 pandemic will bridge the gap between science and policy, particularly in healthcare and tobacco harm reduction.

Recently, according to Allafrica, amidst the COVID-19 pandemic, there was a widespread belief in the scientific community that this crisis would bridge the gap between scientific data and policy formulation, potentially leading to evidence-based regulations. However, the reality has shown that in the short term, this hasn't occurred in the development of health policies or subsequent Tobacco Harm Reduction (THR) policies.


According to data, the growth rate of the new nicotine product industry has exceeded expectations, with the global market value projected to surpass $50 billion and the user base exceeding 100 million. However, the nicotine industry is currently facing severe setbacks due to challenges such as regulation, taxation, and bans.


The stringent regulation of new nicotine products has also been criticized by the American Psychological Association for the dissemination of incorrect information, which they interpret as misinformation or factual inaccuracies. Although the term is often used interchangeably with "fake news," experts argue that fake news is intentionally used to mislead facts.


Professor Solomon Rataemane, dean of the School of Psychology at the University of South Africa, has highlighted that the new legislation aiming to regulate the tobacco industry in South Africa has received widespread criticism from various stakeholders. According to him, critics argue that novel tobacco products such as e-cigarettes might have a positive impact on reducing tobacco-related harm, as they could potentially improve lung function among users.


Professor Giuseppe Biondi Zoccai, Associate Professor of Cardiology at the Catholic University of Rome, stated that despite scientific evidence indicating numerous health benefits of current nicotine products, such evidence is not sufficient to convince decision-makers to make the right decisions.


Mrs. Marewa Glover, when discussing New Zealand being widely perceived as a successful case, stated that their policies should no longer be copied as the best examples.


She emphasized that education should be the top priority, not taxes. In New Zealand, taxes are so high compared to income that the lowest socio-economic smoking groups often can no longer afford to buy legal cigarettes, leading to other issues. People turn to the black market or cut funds from their food budgets. Many policies have negative consequences, particularly for the lowest socio-economic groups, but good policies should take these impacts into consideration.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Survey Shows E-cigarette Use Doubles Among Young Thais
Survey Shows E-cigarette Use Doubles Among Young Thais
Thailand’s latest national health survey shows a sharp increase in e-cigarette use among people under 30, particularly among female adolescents. Researchers found that vaping has not reduced overall tobacco harm and has instead driven growth in new nicotine users, with younger ages of initiation. Public health experts urged sustained enforcement and comprehensive policies centred on banning e-cigarettes, strengthening law enforcement and expanding public awareness to protect children and youth.
Dec.19 by 2FIRSTS.ai
Product | AutoFresh Lock + Transparent Tank: SKE’s MEMERS VAPE Launches New Device
Product | AutoFresh Lock + Transparent Tank: SKE’s MEMERS VAPE Launches New Device
SKE-owned MEMERS has listed the disposable FRESA 40K on its website, featuring a transparent e-liquid chamber and a battery level display, with a claimed up to 40,000 puffs. The device uses Fresh Lock+ auto oil-lock to isolate e-liquid from the coil; brand materials cite two trigger timings—6 seconds after each puff or after 5 minutes of inactivity. It includes a 900mAh rechargeable battery, Type-C charging, and comes in 10 flavors.
Nov.05 by 2FIRSTS.ai
Russia’s State Duma May Soon Consider Full Ban on Vape Sales
Russia’s State Duma May Soon Consider Full Ban on Vape Sales
Russia’s State Duma will soon consider a proposal to impose a complete ban on the sale of vapes. The move follows President Vladimir Putin’s endorsement of a nationwide prohibition. Lawmaker Aleksey Volotskov said vape use has surged by 52% since early 2025, with illegal products now dominating 80% of the market.
Nov.11 by 2FIRSTS.ai
Hungary’s Continental Tobacco Launches New Slay Nicotine Pouch Brand in UK Targeting Female Consumers
Hungary’s Continental Tobacco Launches New Slay Nicotine Pouch Brand in UK Targeting Female Consumers
Hungary’s Continental Tobacco Group has launched its Slay nicotine pouch brand in the UK, featuring compact, pastel-toned packaging and backed by a multi-million-pound investment and retail pilot programme to build its presence in the local market.
Dec.03 by 2FIRSTS.ai
Special Report|With Charlie’s US Line Online, the US-Filled Vape Supply Chain Model Enters a New Phase
Special Report|With Charlie’s US Line Online, the US-Filled Vape Supply Chain Model Enters a New Phase
Charlie’s Holdings has activated its first US-based manufacturing and filling line, enabling the company’s Pachamama 25K vape series to meet Texas’ new domestic manufacturing requirements. As state-level rules tighten, the move signals a broader industry shift toward US-filled supply chains and marks an inflection point for brands historically reliant on China-based prefilled production.
Industry Insight
Dec.02
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20